Cargando…

Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy

Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Yumei, Lin, Kun, Fang, Jun, Ding, Yang, Zhang, Zhang, Chen, Xiaojia, Zhao, Qiu, Wang, Haizhou, Wang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173364/
https://www.ncbi.nlm.nih.gov/pubmed/37181656
http://dx.doi.org/10.1016/j.csbj.2023.04.016
_version_ 1785039803785412608
author Ning, Yumei
Lin, Kun
Fang, Jun
Ding, Yang
Zhang, Zhang
Chen, Xiaojia
Zhao, Qiu
Wang, Haizhou
Wang, Fan
author_facet Ning, Yumei
Lin, Kun
Fang, Jun
Ding, Yang
Zhang, Zhang
Chen, Xiaojia
Zhao, Qiu
Wang, Haizhou
Wang, Fan
author_sort Ning, Yumei
collection PubMed
description Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein, we conducted a comprehensive pan-cancer analysis of MS subtypes across seven GI-cancer types. Using unsupervised clustering based on literature-derived MS-specific pathway signatures, the GI-tumor samples were divided into three MS subtypes, termed as the Soft, Mixed and Stiff. Then, distinct prognoses, biological features, tumor microenvironments and mutation landscapes among three MS subtypes were revealed. The Stiff tumor subtype was associated with the poorest prognosis, the most malignant biological behaviors, and the immunosuppressive tumor stromal microenvironment. Furthermore, multiple machine learning algorithms were used to develop an 11-gene MS-signature to identify the MS subtypes of GI-caner and predict chemotherapy sensitivity, which were further validated in two external GI-cancer cohorts. This novel MS-based classification on GI-cancers could enhance our understanding of the important role of MS in tumor progression, and may have implications for the optimization of individualized cancer management.
format Online
Article
Text
id pubmed-10173364
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-101733642023-05-12 Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy Ning, Yumei Lin, Kun Fang, Jun Ding, Yang Zhang, Zhang Chen, Xiaojia Zhao, Qiu Wang, Haizhou Wang, Fan Comput Struct Biotechnol J Research Article Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein, we conducted a comprehensive pan-cancer analysis of MS subtypes across seven GI-cancer types. Using unsupervised clustering based on literature-derived MS-specific pathway signatures, the GI-tumor samples were divided into three MS subtypes, termed as the Soft, Mixed and Stiff. Then, distinct prognoses, biological features, tumor microenvironments and mutation landscapes among three MS subtypes were revealed. The Stiff tumor subtype was associated with the poorest prognosis, the most malignant biological behaviors, and the immunosuppressive tumor stromal microenvironment. Furthermore, multiple machine learning algorithms were used to develop an 11-gene MS-signature to identify the MS subtypes of GI-caner and predict chemotherapy sensitivity, which were further validated in two external GI-cancer cohorts. This novel MS-based classification on GI-cancers could enhance our understanding of the important role of MS in tumor progression, and may have implications for the optimization of individualized cancer management. Research Network of Computational and Structural Biotechnology 2023-04-20 /pmc/articles/PMC10173364/ /pubmed/37181656 http://dx.doi.org/10.1016/j.csbj.2023.04.016 Text en © 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Ning, Yumei
Lin, Kun
Fang, Jun
Ding, Yang
Zhang, Zhang
Chen, Xiaojia
Zhao, Qiu
Wang, Haizhou
Wang, Fan
Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title_full Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title_fullStr Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title_full_unstemmed Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title_short Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
title_sort gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173364/
https://www.ncbi.nlm.nih.gov/pubmed/37181656
http://dx.doi.org/10.1016/j.csbj.2023.04.016
work_keys_str_mv AT ningyumei gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT linkun gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT fangjun gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT dingyang gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT zhangzhang gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT chenxiaojia gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT zhaoqiu gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT wanghaizhou gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy
AT wangfan gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy